| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787674 | Journal of Thoracic Oncology | 2018 | 9 Pages |
Abstract
We developed a failure site-specific competing risk model based on patient- and lesion-level characteristics. Failure patterns differed between adenocarcinoma and squamous cell carcinoma, illustrating the limitation of aggregating them into NSCLC. Failure site-specific models add complementary information to conventional prognostic models.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Lotte MD, Ivan R. PhD, DMSci, Barbara M. MD, PhD, DMSci, Andreas MD, PhD, DMSci, Seppo W. MD, PhD, Marianne C. PhD, Gitte F. MD, PhD, Søren M. PhD, DMSci,